While peri-implant mucositis is considered a reversible inflammatory condition limited to the soft tissues surrounding dental implants, peri-implantitis represents a far more destructive process characterized by progressive bone loss and potential implant failure.
Understanding the biological, clinical, and radiographic differences between these two entities is essential for early diagnosis, prevention, and successful long-term implant maintenance.
The article “Peri-implant mucositis and peri-implantitis: key features and differences” published in Nature provides a valuable and updated overview of the current concepts surrounding peri-implant diseases.
It highlights the importance of biofilm control, patient-related risk factors such as smoking and history of periodontitis, as well as the critical role of supportive peri-implant therapy in preventing disease progression.
Clinically, peri-implant mucositis may present with bleeding on probing, redness, swelling, and increased probing depths without radiographic bone loss beyond initial remodeling.
In contrast, peri-implantitis involves inflammatory tissue destruction associated with progressive peri-implant bone loss, deeper periodontal pockets, suppuration, and, in advanced cases, implant instability.
The article also emphasizes that early intervention during the mucositis stage can significantly reduce the risk of developing peri-implantitis.
For clinicians involved in implant therapy, recognizing subtle inflammatory changes around implants and implementing individualized maintenance protocols are fundamental steps toward preserving implant longevity and improving patient outcomes.
As implant dentistry continues to evolve globally, education on peri-implant disease prevention and management becomes increasingly important for both specialists and general practitioners.
📖 Read the complete article in PDF and explore the latest evidence regarding peri-implant mucositis and peri-implantitis, including diagnostic criteria, risk factors, and therapeutic approaches.
